Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.

Saved in:
Bibliographic Details
Title: Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
Authors: Nissen SE (AUTHOR), Nicholls SJ (AUTHOR), Wolski K (AUTHOR), Rodés-Cabau J (AUTHOR), Cannon CP (AUTHOR), Deanfield JE (AUTHOR), Després JP (AUTHOR), Kastelein JJ (AUTHOR), Steinhubl SR (AUTHOR), Kapadia S (AUTHOR), Yasin M (AUTHOR), Ruzyllo W (AUTHOR), Gaudin C (AUTHOR), Job B (AUTHOR), Hu B (AUTHOR), Bhatt DL (AUTHOR), Lincoff AM (AUTHOR), Tuzcu EM (AUTHOR), STRADIVARIUS Investigators (CORPORATE AUTHOR), Nissen, Steven E1 (AUTHOR)
Source: JAMA: Journal of the American Medical Association. 4/2/2008, Vol. 299 Issue 13, p1547-1560. 14p.
Database: Academic Search Ultimate
Description
ISSN:00987484
DOI:10.1001/jama.299.13.1547